Vir Combination Liquid
NDC Package 43742-2193-1
Package Information
Vir Combination (adenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum (2023-2024)) liquids is 1-10 drops under the tongue, 3 times a day or as directed by a health professional. This formulation utilizes a liquid delivery system. Marketed by Deseret Biologicals, Inc., this product is identified by NDC 43742-2193.
Identification & Billing
Clinical Specifications
- HEPATITIS B VIRUS 33 [hp_X]/mL
- HERRING SPERM DNA 12 [hp_X]/mL
- HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN 12 [hp_C]/mL
- HUMAN HERPESVIRUS 1 15 [hp_X]/mL
- HUMAN HERPESVIRUS 2 15 [hp_X]/mL
- HUMAN HERPESVIRUS 4 16 [hp_C]/mL
- HUMAN HERPESVIRUS 5 18 [hp_X]/mL
- HUMAN HERPESVIRUS 6 15 [hp_X]/mL
- INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE 12 [hp_C]/mL
- INFLUENZA A VIRUS WHOLE 12 [hp_C]/mL
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE 12 [hp_C]/mL
- INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE 12 [hp_C]/mL
Regulatory & Marketing
Hierarchy Structure
- 43742 - Deseret Biologicals, Inc.
- 43742-2193 - Vir Combination
- 43742-2193-1 - 30 mL in 1 BOTTLE, DROPPER
- 43742-2193 - Vir Combination
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43742-2193-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Vir Combination, a human over the counter drug labeled by Deseret Biologicals, Inc.. This liquid is formulated for oral use and contains hepatitis b virus; herring sperm dna; human adenovirus e serotype 4 strain cl-68578 antigen; human herpesvirus 1; human herpesvirus 2; human herpesvirus 4; human herpesvirus 5; human herpesvirus 6; influenza a virus a/darwin/6/2021 (h3n2) whole; influenza a virus whole; influenza b virus b/austria/1359417/2021 bvr-26 whole; influenza b virus b/phuket/3073/2013 bvr-1b whole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deseret Biologicals, Inc. on August 26, 2024.
How is this Deseret Biologicals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43742219301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.